Byam Rebecca
HCW Biologics Inc. · Chief Financial Officer
Byam Rebecca is listed in filings as Chief Financial Officer at HCW Biologics Inc.. This profile follows SEC Form 4 activity through May 27, 2026, including purchase activity. Recent filings connect the profile to HCW Biologics Inc. (HCWB). The current snapshot covers public activity from May 9, 2025 to May 27, 2026. Reported amounts are shown as $20.0K to $220.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $220k8.5k shares | BuyMay 8, 2025 | $26.00 | $4.00 | |
| $110k4.2k shares | BuyMay 7, 2025 | $26.00 | $4.00 |